New Thieno-[2,3-d]pyrimidine-Based Functional Antagonist for the Receptor of Thyroid Stimulating Hormone

被引:12
作者
Derkach, K. V. [1 ]
Bakhtyukov, A. A. [1 ]
Sorokoumov, V. N. [2 ]
Shpakov, A. O. [1 ]
机构
[1] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia
[2] St Petersburg State Univ, Inst Chem, St Petersburg 198504, Russia
基金
俄罗斯科学基金会;
关键词
thyroid stimulating hormone receptor; antagonist; thienopyrimidine; thyroid gland; THYROTROPIN RECEPTOR; TSH RECEPTOR; AGONISTS;
D O I
10.1134/S1607672920020064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thyroid stimulating hormone (TSH) receptor antagonists are required for the treatment of TSH-dependent tumors and Graves disease. We developed the compound 5-amino-N-(tert-butyl)-4-(4-iodophenyl)-2-(methylthio)thieno[2,3-d]pyrimidine-6-carboxamide (TP48) and showed that it reduces the TSH-stimulated adenylate cyclase activity in rat thyroid membranes. Pretreatment of rats with compound TP48 (ip, 40 mg/kg) reduced the increase in the levels of total and free thyroxin in blood and the increase in the expression of thyroglobulin and D2 deiodinase genes in the thyroid gland, which are responsible for the synthesis of thyroid hormones, which were caused by intranasal administration of thyroliberin to animals (300 mu g/kg). These data indicate that compound TP48 is a functional antagonist of the TSH receptor and can be used to correct the thyroid status in hyperthyroidism.
引用
收藏
页码:77 / 80
页数:4
相关论文
共 14 条
[1]   Thyroid hormone biosynthesis and release [J].
Carvalho, Denise P. ;
Dupuy, Corinne .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2017, 458 (0C) :6-15
[2]   In vitro and in vivo studies of functional activity of new low molecular weight agonists of the luteinizing hormone receptor [J].
Derkach K.V. ;
Dar’in D.V. ;
Bakhtyukov A.A. ;
Lobanov P.S. ;
Shpakov A.O. .
Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology, 2016, 10 (4) :294-300
[3]   The Influence of Intranasal Insulin on Hypothalamic-Pituitary-Thyroid Axis in Normal and Diabetic Rats [J].
Derkach, K. V. ;
Bogush, I. V. ;
Berstein, L. M. ;
Shpakov, A. O. .
HORMONE AND METABOLIC RESEARCH, 2015, 47 (12) :916-924
[4]   Molecular sampling of the allosteric binding pocket of the TSH receptor provides discriminative pharmacophores for antagonist and agonists [J].
Hoyer, Inna ;
Haas, Ann-Karin ;
Kreuchwig, Annika ;
Schuelein, Ralf ;
Krause, Gerd .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 :213-217
[5]   Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at work [J].
Kleinau, Gunnar ;
Worth, Catherine L. ;
Kreuchwig, Annika ;
Biebermann, Heike ;
Marcinkowski, Patrick ;
Scheerer, Patrick ;
Krause, Gerd .
FRONTIERS IN ENDOCRINOLOGY, 2017, 8
[6]   A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy [J].
Marcinkowski, Patrick ;
Hoyer, Inna ;
Specker, Edgar ;
Furkert, Jens ;
Rutz, Claudia ;
Neuenschwander, Martin ;
Sobottka, Sebastian ;
Sun, Han ;
Nazare, Marc ;
Berchner-Pfannschmidt, Utta ;
Von kries, Jens Peter ;
Eckstein, Anja ;
Schuelein, Ralf ;
Krause, Gerd .
THYROID, 2019, 29 (01) :111-123
[7]   Discovery and development of small molecule allosteric modulators of glycoprotein hormone receptors [J].
Nataraja, Selvaraj G. ;
Yu, Henry N. ;
Palmer, Stephen S. .
FRONTIERS IN ENDOCRINOLOGY, 2015, 6
[8]   Small molecule TSHR agonists and antagonists [J].
Neumann, S. ;
Gershengorn, M. C. .
ANNALES D ENDOCRINOLOGIE, 2011, 72 (02) :74-76
[9]   A Low-Molecular-Weight Antagonist for the Human Thyrotropin Receptor with Therapeutic Potential for Hyperthyroidism [J].
Neumann, Susanne ;
Kleinau, Gunnar ;
Costanzi, Stefano ;
Moore, Susanna ;
Jiang, Jian-kang ;
Raaka, Bruce M. ;
Thomas, Craig J. ;
Krause, Gerd ;
Gershengorn, Marvin C. .
ENDOCRINOLOGY, 2008, 149 (12) :5945-5950
[10]  
Nunez MiguelR., 2017, AUTOIMMUN HIGHLIGHTS, V8, P2, DOI [10.1007/s13317-016-0090-1, DOI 10.1007/S13317-016-0090-1]